STEPH Washington was diagnosed with stage four cancer after medics dismissed her symptoms as a STI for a year – and she doesn ...

In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

I don't want to be explaining to my daughters why we've still failed to make progress on gynaecological cancers, writes Elise ...

M-Strip, the self-sampling kit for cervical cancer (HPV) and STI screening, provides a non-invasive alternative to ...

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Global disparities exist in the burden of cervical cancer. Only 11 out of the 185 countries and regions reported an age-standardized incidence rates (ASIR) lower than the World Health Organization’s ...

Cervical cancer is a type of cancer that originates in the cervix—the lower part of the uterus that connects to the vagina.

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.